Tag : cannabinoids

CCT Impact

Cannassure was granted a patent for an oral delivery method of cannabis and cannabinoids compositions by the Israel Patents Authority

CCT IMPACT Agent
Cannassure Therapeutics Ltd (TASE: CSURE) (“Cannassure”), an Israel based developer and producer of innovative medical cannabis products, announces today that the company was granted a patent for an oral delivery method of cannabis and cannabinoids compositions by the Israel Patents Authority. The company’s innovative technology enables the provision of an exact amount of active ingredients......
CCT Impact

SciSparc to Support 31st Annual ICRS Symposium on Cannabinoids Special Event

CCT IMPACT Agent
SciSparc Ltd. (formerly known as Therapix Biosciences Ltd.) (OTCQB: SPRCY) (“SciSparc” or the “Company”), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced it will take part and support the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids. This year the event will be held......
CCT Impact

BioMedican Discovers New Class of Cannabinoids; Sesqui CBG

CCT IMPACT Agent
BioMedican has discovered a patent-pending process to biosynthesize a new class of rare Cannabinoids called Sesqui-Cannabinoids. In this class of rare Cannabinoids, there is only one paper that describes the properties of Sesqui-CBG in 2011, but there are several articles that note the presence of Sesqui-CBGA or even Sesqui-CBDA in plants, but only in......
CCT Impact

InMed Licenses MiDROPS® Delivery Technology from EyeCRO for the Delivery of Therapeutic Cannabinoids

CCT IMPACT Agent
InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (NASDAQ:INM) (TSX:IN), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannabinol (“CBN”), today announced that it has secured an exclusive, worldwide license from EyeCRO LLC for its Microemulsion Drug Ocular......
Market Watch

Demetrix Begins Demo Scale Production Of Rare Cannabinoids

CCT IMPACT Agent
Demetrix Inc., a biotechnology company that makes safe and effective cannabinoids, today announced that it has commenced 15,000-liter demo-scale fermentation production of the rare cannabinoid cannibigerol (CBG). The company’s demo-scale production follows the successful completion of numerous pilot-scale fermentations and is a critical milestone towards the commercialization of rare cannabinoids......
Market Watch

Cannabis’ First Portable HPLC Now Delivers 11+ Cannabinoids

CCT IMPACT Agent
Orange Photonics, a cannabis testing instrumentation provider, announced the release of LightLab 3 its next generation, portable, high-performance liquid chromatography-based analyzer. LightLab is designed for non-technical users in cannabis-specific testing applications. LightLab 3 Cannabis Analyzer LightLab 3 results screen featuring all modules Cannabis and Hemp touching businesses and regulators have......
CCT Impact

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Receives New U.S. Patent Issuance for Chewing Gum Comprising Cannabinoids and Nicotine

CCT IMPACT Agent
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech” or “AXIM”) has been issued a Notice of Allowance for a patent from the United......
CCT Impact

Australis Capital and Folium Biosciences Agree to Merger to Create a Publicly Held Vertically Integrated Producer of Non-Psychoactive Cannabinoids

CCT IMPACT Agent
Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (the “Company” or “AUSA“) is pleased to announce it has entered into an agreement and plan of merger by and among AUSA, Folium Equity Holding LLC (“Folium“), and Folium Merger Sub, LLC, a newly formed and wholly-owned Colorado subsidiary of AUSA, (“Merger Sub“) pursuant to which AUSA will acquire......
Featured

CCT Interview with Jeremy Diehl, Co- Founder & CTO of Green Mill Supercritical

Editor
Green Mill Supercritical is a company out of Pittsburgh, Pennsylvania focused on offering their customers involved in the cannabis industry state-of-the-art, fully automated, CO2 extraction machines. ______________________________________________________________ 1) How did the company get started? What in your career lead you to running Green Mill Supercritical? I spent my entire career......
Global Health Hemp News Market Watch

GW Pharma to Raise $300M Via Public Offering

Editor
GW Pharmaceuticals plc (NASDAQ: GWPH) announced this morning that the company’s wholly owned subsidiary, Greenwich Biosciences, plans to raise $300 million dollars via the selling GW Pharma’s common shares on the NASDAQ Global Market. The company is planning to offer the underwriters an additional 30-day option to purchase an additional $45......